14945-17-6 ((Vasopressin,8-L-lysine-9-D-alaninamide- (8CI,9CI))

Vasopressin,8-L-lysine-9-D-alaninamide- (8CI,9CI);vasopressin, 9-Ala-NH(2)-Lys-;1-{[19-amino-7-(2-amino-2-oxoethyl)-10-(3-amino-3-oxopropyl)-13-benzyl-16-(4-hydroxybenzyl)-6,9,12,15,18-pentaoxo-1,2-dithia-5,8,11,14,17-pentaazacycloicosan-4-yl]carbonyl}prolyllysylalaninamide;9-Ala-NH(2)-lys-vasopressin;9-Alaninamide-lysine vasopressin;Vasopressin, 8-L-lysine-9-D-alaninamide-, (T-4)-;Vasopressin, 9-alaninamide-lysine-;14945-17-6;1-[19-amino-7-(2-amino-2-oxoethyl)-10-(3-amino-3-oxopropyl)-13-benzyl-16-[(4-hydroxyphenyl)methyl]-6,9,12,15,18-pentaoxo-1,2-dithia-5,8,11,14,17-pentazacycloicosane-4-carbonyl]-N-[6-amino-1-[(1-amino-1-oxopropan-2-yl)amino]-1-oxohexan-2-yl]pyrrolidine-2-carboxamide;

KEXFJVLUVBJIMD-UHFFFAOYSA-N

1S/C47H67N13O12S2/c1-25(39(52)64)53-41(66)30(10-5-6-18-48)55-46(71)36-11-7-19-60(36)47(72)35-24-74-73-23-29(49)40(65)56-32(21-27-12-14-28(61)15-13-27)44(69)57-33(20-26-8-3-2-4-9-26)43(68)54-31(16-17-37(50)62)42(67)58-34(22-38(51)63)45(70)59-35/h2-4,8-9,12-15,25,29-36,61H,5-7,10-11,16-24,48-49H2,1H3,(H2,50,62)(H2,51,63)(H2,52,64)(H,53,66)(H,54,68)(H,55,71)(H,56,65)(H,57,69)(H,58,67)(H,59,70)

S1CC(C(N2CCCC2C(NC(C(NC(C(N)=O)C)=O)CCCCN)=O)=O)NC(C(CC(N)=O)NC(C(CCC(N)=O)NC(C(CC2C=CC=CC=2)NC(C(CC2C=CC(=CC=2)O)NC(C(CS1)N)=O)=O)=O)=O)=O